Cadian Capital Management, LP is an SEC-registered investment adviser based in New York, NY that reports managing 3 hedge funds on Form ADV. It reports $2.7 billion in regulatory assets under management. Its private funds, of all types, hold $2.7 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated -0.1% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +31.9% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- $2.7 billionForm ADV Item 5.F
- Gross assets of private funds
- $2.7 billionAll private fund types, Form ADV
- Hedge funds managed
- 33 private funds in total
- Employees
- 20Form ADV Item 5.A
- Registration
- SEC-registered adviserCRD 157813
- Latest Form ADV
- 09/18/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
Estimated by AltMountain, derived from the firm’s public Form 13F filings. Not reported by the firm and not the return of any fund.
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | +31.8% | +14.8% |
| Q1 2026 | -24.2% | -4.6% |
| Q4 2025 | +6.4% | +2.4% |
| Q3 2025 | +0.4% | +7.8% |
| Q2 2025 | +3.4% | +10.4% |
| Q1 2025 | -6.4% | -4.5% |
| Q4 2024 | +24.9% | +2.1% |
| Q3 2024 | +2.2% | +5.4% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Manager of this firm? Report your fund’s actual net return, or email hello@altmountain.com to correct or remove this estimate. Removal requests from the firm are honored.
13F holdings as of Sep 30, 2026
All 26 share positions ($1,199,269,956) reported by Cadian Capital Management, LP on Form 13F for the quarter ended Sep 30, 2026, filed Nov 16, 2026. Shown as filed with the SEC. Original filing on SEC.gov ↗ The estimated return above runs through Jun 30, 2026; it is updated when the SEC publishes its complete data for the quarter.
Share of the reported 13F portfolio, ten largest positions
- Iqvia Hldgs Inc12.05%
- Flywire Corporation11.21%
- Insulet Corp9.65%
- Guardant Health Inc7.43%
- Amazon Com Inc7.11%
- Si Bone Inc5.94%
- Spotify Technology S A5.87%
- Procore Technologies Inc4.87%
- Danaher Corp Del4.80%
- Tactile SYS Technology Inc4.16%
| Stock | Value | % of 13F portfolio | Shares | Shares vs prior quarter |
|---|---|---|---|---|
| Iqvia Hldgs Inc | $144,565,753 | 12.05% | 537,719 | -34.08% |
| Flywire Corporation | $134,393,123 | 11.21% | 7,679,607 | +33.69% |
| Insulet Corp | $115,739,937 | 9.65% | 887,100 | New |
| Guardant Health Inc | $89,093,317 | 7.43% | 499,514 | -34.05% |
| Amazon Com Inc | $85,307,714 | 7.11% | 342,395 | +90.54% |
| Si Bone Inc | $71,280,144 | 5.94% | 3,791,497 | +13.26% |
| Spotify Technology S A | $70,455,653 | 5.87% | 144,560 | -16.92% |
| Procore Technologies Inc | $58,462,840 | 4.87% | 1,130,372 | +33.77% |
| Danaher Corp Del | $57,569,989 | 4.80% | 259,851 | -20.31% |
| Tactile SYS Technology Inc | $49,893,156 | 4.16% | 2,238,365 | +41.94% |
| Cryoport Inc | $42,089,678 | 3.51% | 2,418,947 | -17.18% |
| Descartes SYS Group Inc | $41,044,536 | 3.42% | 507,600 | New |
| Intapp Inc | $39,276,987 | 3.28% | 1,084,700 | -50.25% |
| Varonis SYS Inc | $37,404,076 | 3.12% | 788,284 | -50.29% |
| Nutanix Inc | $32,008,668 | 2.67% | 454,604 | -24.17% |
| Tyler Technologies Inc | $26,706,008 | 2.23% | 83,823 | New |
| Equinix Inc | $24,682,552 | 2.06% | 24,400 | +79.41% |
| Omniab Inc | $20,890,632 | 1.74% | 4,211,821 | Unchanged |
| Alkami Technology Inc | $14,976,696 | 1.25% | 1,093,988 | -25.92% |
| Workiva Inc | $11,142,620 | 0.93% | 167,382 | +16.08% |
| Meta Platforms Inc | $8,702,160 | 0.73% | 12,000 | -17.24% |
| Carlsmed Inc | $7,036,351 | 0.59% | 500,096 | New |
| Sotera Health Co | $6,471,500 | 0.54% | 350,000 | Unchanged |
| Verisign Inc | $5,358,190 | 0.45% | 19,000 | -75.95% |
| Maxcyte Inc | $2,939,647 | 0.25% | 2,624,685 | +19.24% |
| Evolent Health Inc | $1,778,029 | 0.15% | 509,464 | -95.29% |
Changes since Jun 30, 2026
Comparing the share counts in the two quarter-end filings: 4 new positions, 6 sold out, 8 increased, 12 reduced and 2 unchanged.
Number of positions (a count, not dollars)
- New positions4
- Increased8
- Unchanged2
- Reduced12
- Sold out6
New positions
| Stock | Value | Shares |
|---|---|---|
| Insulet Corp | $115,739,937 | 887,100 |
| Descartes SYS Group Inc | $41,044,536 | 507,600 |
| Tyler Technologies Inc | $26,706,008 | 83,823 |
| Carlsmed Inc | $7,036,351 | 500,096 |
Sold out
| Stock | Value at Jun 30, 2026 | Shares held then |
|---|---|---|
| Planet Fitness Master Issuer | $83,489,738 | 1,600,340 |
| Monday Com LTD | $68,338,259 | 944,029 |
| Healthequity Inc | $56,603,544 | 626,700 |
| Boston Scientific Corp | $47,167,034 | 1,105,132 |
| Taiwan Semiconductor Manufac | $17,144,763 | 35,900 |
| Medline Inc | $3,944,000 | 100,000 |
Largest increases
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| Amazon Com Inc | +162,695 | +90.54% | $85,307,714 | 342,395 |
| Flywire Corporation | +1,935,441 | +33.69% | $134,393,123 | 7,679,607 |
| Procore Technologies Inc | +285,372 | +33.77% | $58,462,840 | 1,130,372 |
| Tactile SYS Technology Inc | +661,425 | +41.94% | $49,893,156 | 2,238,365 |
| Equinix Inc | +10,800 | +79.41% | $24,682,552 | 24,400 |
| Si Bone Inc | +443,923 | +13.26% | $71,280,144 | 3,791,497 |
| Workiva Inc | +23,182 | +16.08% | $11,142,620 | 167,382 |
| Maxcyte Inc | +423,519 | +19.24% | $2,939,647 | 2,624,685 |
Largest reductions
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| Iqvia Hldgs Inc | -278,033 | -34.08% | $144,565,753 | 537,719 |
| Guardant Health Inc | -257,879 | -34.05% | $89,093,317 | 499,514 |
| Intapp Inc | -1,095,552 | -50.25% | $39,276,987 | 1,084,700 |
| Varonis SYS Inc | -797,409 | -50.29% | $37,404,076 | 788,284 |
| Evolent Health Inc | -10,305,009 | -95.29% | $1,778,029 | 509,464 |
| Verisign Inc | -60,000 | -75.95% | $5,358,190 | 19,000 |
| Danaher Corp Del | -66,212 | -20.31% | $57,569,989 | 259,851 |
| Spotify Technology S A | -29,440 | -16.92% | $70,455,653 | 144,560 |
| Nutanix Inc | -144,900 | -24.17% | $32,008,668 | 454,604 |
| Cryoport Inc | -501,734 | -17.18% | $42,089,678 | 2,418,947 |
| Alkami Technology Inc | -382,844 | -25.92% | $14,976,696 | 1,093,988 |
| Meta Platforms Inc | -2,500 | -17.24% | $8,702,160 | 12,000 |
Each list shows up to 20 positions, largest first by dollar amount. Changes compare two quarter-end snapshots, with the earlier share count adjusted for stock splits AltMountain detected. They do not show when, or at what price, anything was bought or sold.
From public Form 13F filings, not verified. Form 13F is filed up to 45 days after the quarter ends, so positions may have changed. It lists only certain long positions in U.S.-listed stocks and exchange-traded funds; options are not shown here, and short positions, most bonds, cash, non-U.S. securities and private investments are not reported at all, so a holding may be one side of a hedge. A filing covers the manager as a whole, not any single fund, and filings contain errors. This is not investment advice or a recommendation to buy or sell any security. Disclosures
Large ownership stakes (Schedule 13D and 13G)
| Company | Filing | Percent of class | Shares | Filed | Source |
|---|---|---|---|---|---|
| Tactile Systems Technology, Inc. | 13G amendment | 9.9% | 2,238,365 | Nov 16, 2026 | SEC.gov ↗ |
| Flywire Corporation | 13G | 6.3% | 7,679,607 | Nov 16, 2026 | SEC.gov ↗ |
| Evolent Health, Inc. | 13G amendment | 0.5% | 509,464 | Nov 16, 2026 | SEC.gov ↗ |
| Cryoport, Inc. | 13G amendment | 4.8% | 2,418,947 | Nov 16, 2026 | SEC.gov ↗ |
| SI-BONE, Inc. | 13G | 7.5% | 3,347,574 | Aug 14, 2026 | SEC.gov ↗ |
| Maxcyte, Inc. | 13G amendment | 3.5% | 3,683,052 | Feb 17, 2026 | SEC.gov ↗ |
| Sprout Social, Inc. | 13G amendment | 0% | 0 | Feb 17, 2026 | SEC.gov ↗ |
| Criteo S.A. | 13G amendment | 4.3% | 2,475,961 | Nov 14, 2025 | SEC.gov ↗ |
A firm files Schedule 13G (passive) or 13D (it may seek to influence the company) when it beneficially owns more than 5% of a class of a public company's shares. Each row is the firm's latest such filing for that company since Nov 14, 2025, exactly as filed, and counts shares held across the firm and its affiliates, not by any single fund. An amendment can report a stake that has fallen below 5%. Holdings may have changed since the filing date. Not verified by AltMountain. Source: U.S. Securities and Exchange Commission, EDGAR.
Hedge funds filing Form D (4)
Matched to this firm by the fund names and related persons in each Form D. The list may be incomplete.
Private equity funds filing Form D (1)
Matched to this firm by the fund names and related persons in each Form D. The list may be incomplete.
Private funds reported on Form ADV (2)
As reported in the adviser's Form ADV filed Mar 29, 2024. Funds also listed from Form D are shown above.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. AltMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures